This policy brief examines the implementation and efficacy of human papillomavirus (HPV) DNA-based and mRNA-based nucleic acid amplification tests (NAATs) in screening and preventing cervical cancer. Cervical cancer remains a significant health issue, particularly in low-resource regions, prompting the World Health Organization (WHO) to set targets for its elimination by 2030. The brief compares the two types of HPV NAATs, their effectiveness in different populations, and their role in screening strategies. It highlights the importance of transitioning to NAAT-based screening programs for improved cancer prevention. The document targets healthcare policymakers and professionals involved in cervical cancer prevention programs, aiming to guide them in adopting effective screening and treatment strategies.
This policy brief examines the implementation and efficacy of human papillomavirus (HPV) DNA-based and mRNA-based nucleic acid amplification tests (NAATs) in screening and preventing cervical cancer. Cervical cancer remains a significant health issue, particularly in low-resource regions, prompti...